Boundless Bio, Inc.
BOLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782303
In the last 90 days, Boundless Bio, Inc. insiders filed 5 open-market purchases and 1 sale; 40 institutions reported holding it in 13F filings for Q2 2026, worth $38.3M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 10, 2026
- $55.7M
- Insider buysLast 90 days, $458.4K in total
- 5
- Insider sellsLast 90 days, $54.4K in total
- 1
- 13F holdersQ2 2026, +5 vs. previous quarter
- 40
- 13F valueReported value at the end of Q2 2026
- $38.3M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- –
- No comparable prior period
- Net income, FY2025
- -$58.2M
- No comparable prior period
- Free cash flow, FY2025
- -$47.2M
- No comparable prior period
- Revenue, Q3 FY2026
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 790.3K
- Shares sold short
- Change
- +1.82K
- +0.2% vs. previous
- Days to cover
- 5.06
- At average daily volume
Superinvestors holding BOLD, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding BOLD at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Boundless Bio, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 (view filing)5:09 PM ET | Nov 6-10 | 4 days | Tang Kevin C and 1 other10% Owner | PPurchase | +1.95K | $2.40 | +$4.68K | +0.1%3.04M after | 2 lots |
| Nov 5, 2026 (view filing)6:14 PM ET | Nov 3-5 | 2 days | Tang Kevin C and 1 other10% Owner | PPurchase | +11.2K | $2.40 | +$26.8K | +0.4%3.03M after | 3 lots |
| Oct 29, 2026 (view filing)6:20 PM ET | Oct 27 | 2 days | Tang Kevin C and 1 other10% Owner | PPurchase | +10.7K | $2.40 | +$25.7K | +0.4%3.02M after | |
| Oct 26, 2026 (view filing)4:51 PM ET | Oct 22-26 | 4 days | Tang Kevin C and 1 other10% Owner | PPurchase | +21.6K | $2.39 | +$51.6K | +0.7%3.01M after | 3 lots |
| Oct 20, 2026 (view filing)5:49 PM ET | Oct 16-20 | 4 days | Tang Kevin C and 1 other10% Owner | PPurchase | +149.5K | $2.34 | +$349.6K | +5.3%2.99M after | 4 lots |
| Aug 28, 2026 (view filing)4:16 PM ET | Aug 26 | 2 days | Tang Kevin C and 1 other10% Owner | SSale | −18.3K | $2.97 | −$54.4K | −0.6%2.84M after | |
| Jul 21, 2026 (view filing)7:38 PM ET | Jul 17-21 | 4 days | Tang Kevin C and 1 other10% Owner | PPurchase | +4.86K | $2.44 | +$11.9K | +0.2%2.86M after | 3 lots |
| Jul 16, 2026 (view filing)8:10 PM ET | Jul 14-16 | 2 days | Tang Kevin C and 1 other10% Owner | PPurchase | +64.0K | $2.43 | +$155.6K | +2.3%2.85M after | 3 lots |
| Jul 13, 2026 (view filing)7:06 PM ET | Jul 9-13 | 4 days | Tang Kevin C and 1 other10% Owner | PPurchase | +91.6K | $2.42 | +$222.1K | +3.4%2.79M after | 3 lots |
| Jul 8, 2026 (view filing)8:06 PM ET | Jul 6-8 | 2 days | Tang Kevin C and 1 other10% Owner | PPurchase | +57.2K | $2.48 | +$141.9K | +2.2%2.70M after | 3 lots |
Top 10 13F holders, Q2 2026
See all 40 holdersThe largest institutional positions in Boundless Bio, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ARCH Venture Management, LLC | 2,694,095 | $6.74M | 0.61% | +2,694,095 | New |
| FMR LLC | 2,581,055 | $6.45M | 0.00% | −114,400−4.2% | Reduced |
| Tang Capital Management LLC | 2,559,875 | $6.40M | 0.29% | +2,559,875 | New |
| ADAR1 Capital Management, LLC | 1,968,216 | $4.92M | 0.23% | +1,968,216 | New |
| Cormorant Asset Management, LP | 1,000,000 | $2.50M | 0.13% | +1,000,000 | New |
| Vanguard Capital Management LLC | 614,923 | $1.54M | 0.00% | +17,731+3.0% | Added |
| Wellington Management Group LLP | 556,233 | $1.39M | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 478,639 | $1.20M | 0.00% | +378,764+379.2% | Added |
| Renaissance Technologies LLC | 471,570 | $1.18M | 0.00% | +72,570+18.2% | Added |
| Alyeska Investment Group, L.P. | 300,000 | $750.0K | 0.00% | 00.0% | Unchanged |
Holders of 5% or more of BOLD
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Boundless Bio, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 13G/A | 12.00%2.68M shares | – | Apr 10, 20242 filings | Feb 5, 2026 | SEC |
| Tang Capital Management LLC | 13G | 11.30%2.53M shares | New | Jun 29, 20261 filing | Jun 29, 2026 | SEC |
| Hornby Zachary | 13G | 9.80%2.43M shares | New | Aug 27, 20261 filing | Aug 27, 2026 | SEC |
| ADAR1 Capital Management, LLC | 13G | 8.80%1.97M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |